Background
==========

In spite of the increasing involvement of technology in routine antenatal care in both developed and developing countries, the clinical encounter between patient and caregiver still represents the core of the current health care paradigm. At least in theory, any care offered should be acceptable for the recipients. However, the importance of allowing for patients\' views, alongside medical and economic considerations regarding care assessment during pregnancy and childbirth, wasn\'t stressed until the late 80\'s and almost only in developed countries \[[@B1]\].

The importance of caregivers\' views has been acknowledged even less frequently, even though it is a crucial component of any attempt to change institutional protocols. \[[@B2]\] In fact, such views about their own clinical work can strongly influence daily performance and acceptance of institutional protocols and norms \[[@B3]\]. For example, physicians\' attitudes appear to be the most important factor influencing the rate of Caesarean sections \[[@B4]\].

Undoubtedly, patients and caregivers\' perspectives mirror the quality of the care received and provided. However, quality of care has been traditionally a difficult concept to operationalize. As a reflection of the emphasis on the application of advanced technology and specialized training, quality of care has been largely defined in terms of clinical aspects, neglecting social interaction and the subjective dimension of the patient \[[@B5]\]. Only in the last decade and based on Donabedian\'s work \[[@B6]\] did Bruce\'s framework highlight the importance of stressing not only the technical but also the interpersonal domain in the field of family planning \[[@B7]\].

Measuring quality of care conceptualized in such a broad manner represents a true challenge. While the technical quality of a health service can be assessed by evaluating the outcomes of the care provided, the subjective dimension of quality of care (interpersonal relationship with the provider and the system\'s responsiveness to the expectations of the population) can only be assessed through interviews that are strongly influenced by the cultural milieu and the circumstances under which they are conducted. In the field of antenatal care, recent efforts have been made to sort out these various influences \[[@B8]-[@B13]\]; however, the knowledge about users\' views is still very limited, especially in developing countries \[[@B14],[@B15]\]. This paper describes women and providers\' perceptions of the quality of antenatal care (ANC) and their degree of satisfaction with it, alongside a large randomized controlled trial \[[@B16]-[@B18]\].

Methods
=======

The project reported here was a special component of a large multicenter randomized controlled trial, to evaluate a new ANC program \[[@B18]\]. The primary hypotheses tested were that a new ANC model, consisting only of actions scientifically proven to improve maternal and newborn outcomes, was as effective as the traditional model with regard to specified maternal and perinatal end-points among singleton pregnancies, was not more expensive, and was accepted by women and providers \[[@B16]\]. Conducted by WHO and collaborating organizations, fifty-three randomly allocated (cluster randomization) ANC clinics in Argentina, Cuba, Saudi Arabia and Thailand participated in the study, providing either the new program or the traditional program in use. There were 12,568 women randomized to the new model and 11,958 to the standard ANC model \[[@B18]\].

The model in the control clinics was the antenatal care currently offered, following guidelines formally recommended by the local health authorities, based on the traditional western model. In general, women made visits once a month during the first six months, one every 2--3 weeks for the next 2 months, and one every week until delivery. Clinical activities, urinary tests, syphilis screening, hemoglobin measurement, and blood group typing were done routinely.

In the intervention clinics, women judged not to need further assessment or special care at the time of the first visit according to predefined risk criteria were assigned to the new ANC model, which required fewer visits (usually four) with longer spacing between them than the standard ANC model recommended. Activities in the new program included: 1) screening for health conditions likely to increase the risk of adverse pregnancy outcomes; 2) providing interventions known to positively impact pregnancy outcomes, and excluding other common interventions that have not proved beneficial to pregnant women (e.g., maternal weight was measured only during the first visit; subsequent measurement was limited to patients with low weight); and 3) alerting pregnant women to potential health problems, especially emergencies, and instructing them on appropriate responses (e.g., recommendations for emergencies were provided in each visit; at the third visit instructions for delivery and suggestions for breastfeeding and contraception were included) \[[@B16]\]. Results of the general effectiveness of the new ANC model (measured by examining low birth weight for the fetal condition and rates of preeclampsia/eclampsia, severe postpartum anemia, and treated urinary tract infection or pyelonephritis for the maternal conditions) have been published elsewhere \[[@B18]\]. The assessment of women and provider satisfaction with the standard model and the new model is described here.

Study Design
------------

The assessment of women and providers\' perception of the quality of both models of antenatal care was organized in two stages. First, we used an ethnographic approach, including focus group discussions and in-depth interviews with women and health personnel to assess the culture-related values in each country. During the qualitative stage we addressed general topics on health care provision and prenatal programs to gain initial understanding of the way health care was perceived in each specific cultural context \[[@B17]\]. The findings of this in-depth study \[[@B19]\] were incorporated in the second stage (quantitative), which used standardized, closed-ended questionnaires that were prepared based on the most relevant categories obtained at the qualitative stage and the aspects of antenatal care that were expected to change as a result of the intervention (i.e., number of visits, spacing, time with provider, and information provision regarding maternal and perinatal health and complications). Both instruments (one for women, one for providers) were developed in English, translated into Spanish and Arabic, and piloted in each country. Changes suggested in each site were incorporated into the final version of the instruments by the investigators responsible of this component of the trial and then reviewed and approved by a WHO special technical review group. These final English versions (see [Additional File 1 \[Women\'s questionnaire\]](#S1){ref-type="supplementary-material"} and [Additional File 2 \[Providers\' questionnaire\]](#S2){ref-type="supplementary-material"}) were again translated into local languages.

The questionnaire for women consisted of 24 questions addressing patients\' preferences about the number of antenatal care visits; time spent in the waiting room and with the caregiver; and the amount and appropriateness of the information received during the visits. Women were also asked about their worries concerning their health status and their babies\', and the reassurance they received from the provider. Because of the known limited validity of questions that include the word \"satisfaction\", we decided to include only one direct question (\"Are you satisfied with the antenatal care you have received in this clinic so far?\"), adapted from a previous antenatal care trial \[[@B20]\] to facilitate their meta-analysis, and two indirect ones (\"Would you come back to this clinic?\" and \"Would you recommend this clinic to a relative or friend?\"), which were developed based on information gathered from the focus groups (see [Additional File 1](#S1){ref-type="supplementary-material"} \[Women\'s questionnaire\]). We expected the \"satisfaction\" variable to synthesize women\'s overall perceptions of the quality of antenatal care \[[@B17]\].

The questionnaire for providers included 15 questions, probing the same issues as the patients\': number and spacing of antenatal visits, time spent with the woman, information provided, perception of the quality of antenatal care, and recognition of women\'s satisfaction. (see [Additional File 2](#S2){ref-type="supplementary-material"} \[Providers\' questionnaire\])

While some questions were worded per the terminology used in each country, their meaning was retained in the four settings. Both questionnaires were piloted in the four participating areas and adjusted accordingly \[[@B17]\].

Sample size and sampling strategy
---------------------------------

The sample size was estimated to detect a minimum difference between a dissatisfaction rate of 5% in one arm and 10% in the other, with a two-sided test at a significance level of 5%, and with 80% power. The sample size obtained with standard formulas to compare two proportions for individually randomized design was multiplied by a design effect of 1.7 to account for the decrease in efficiency of the cluster randomized design. A sample of 1600 women (800 per arm of the study, 400 per country) was deemed necessary. A design effect of 1.5 had been previously calculated for the outcome of low birth weight \[[@B21]\]. Since this design effect does not necessarily apply to a different outcome, and there was no information regarding design effects or intraclass correlation coefficients from other studies, we arbitrarily increased it to 1.7. The survey used clinics as strata, and women were sampled proportionally to each clinic\'s number of women per year.

The interviewers started surveying all eligible women on a randomly selected day and continued during working days until enrolling the estimated sample size. Because women needed to be sufficiently exposed to ANC in order to form their own opinion on the quality of care they had received, we administered the questionnaire only to patients that were at 32 weeks of gestational age and had attended the health care facility for their second or subsequent antenatal visit. The women were surveyed in a private environment, in approximately 15 minutes. We did not request an individual separate informed consent for this component of the trial but we did have special institutional consent. Therefore, the questionnaire was administered to all women that met the inclusion criteria (i.e., 32 weeks of gestational age and two or more antenatal care visits) in both clinics\' groups until completion of the sample size.

We asked all 174 ANC providers from both intervention and control clinics to complete a self-administered questionnaire that took approximately 10 minutes. We recruited 92 caregivers from the experimental institutions (57 physicians, 33 nurses, and 2 midwives) and 82 from the routine care arm (54 physicians, 25 nurses, and 3 midwives). No provider refused to fill the instrument.

Outcomes
--------

Regarding the women\'s survey, affirmative answers to questions about satisfaction measured overall satisfaction (primary outcome). Other satisfaction dichotomous outcomes were satisfaction with number of visits, spacing between visits, waiting time, and time spent with provider.

Additionally, the following four summary indexes were constructed as outcomes for the women\'s survey: 1) Information received, defined as the number of \'as much as you wanted\' answers provided by a woman to the six questions on information received about looking after own health, tests during pregnancy, any treatment that might be needed during pregnancy, labor, breastfeeding and family planning; 2) Information about how to recognize problems, defined as the number of \'yes\' answers provided by a woman to the six questions on: whether she was told how to recognize the following pregnancy-related problems: rupture of membranes, hemorrhage, premature contractions, dizziness and fainting, fever, and other; 3) Information about what to do in the presence of the above-described problems; and 4) Information about how to recognize and handle these problems. For every woman, each index summarized six questions of the survey, thus the numerical value could vary from 0 to 6.

For the providers\' questionnaire, information given was measured through an index defined as the number of \'yes\' answers to the six questions about health, tests and treatments during pregnancy, labor and delivery, breastfeeding and family planning. This index also ranged from 0 to 6.

Data analysis
-------------

Percentages or mean and standard deviations, as appropriate, were computed by group for baseline variables for the women interviewed, by arm, and checked for imbalance between groups. Baseline statistics for the sub-sample of women interviewed were compared with those for all participants to confirm that they were representative of the main trial population.

For the women\'s survey, the average values of the event rates of satisfaction outcomes were compared between arms, using a rate difference and a t-test at the cluster level, obtaining the standard errors for the difference from a variance analysis adjusted for strata. The indexes were analyzed as numeric outcomes using a random model approach, with clinic and subject as random factors, and arm and strata as fixed factors. Outcomes were adjusted for baseline variables showing a prognostically important imbalance to detect a possible confounding effect.

Since all the clinics\' antenatal caregivers were interviewed, and as they constituted a fixed population, the providers\' questionnaire was analyzed descriptively by computing percentages or mean and standard deviations, as appropriate.

Ethical review
--------------

This component of the study was reviewed and approved as part of the overall ethical review of the WHO trial, which was approved by the Scientific and Ethical Review Group of the UNDP/UNFPA/WHO/World Bank Special Programme on Research, Development and Research Training in Human Reproduction, the WHO Secretariat Committee for Research into Human Subjects, the Institutional Review Boards of the individual participating centres, and corresponding health authorities of the regions where the trial was implemented.

Results
=======

Since this was a randomized controlled trial, the analysis focused on the differences between women and providers in the control clinics as compared to those that offered the new model of ANC.

The comparison between the sub-sample of women recruited for this study and the total trial population showed no significant differences in age, height, weight at first visit, marital status, schooling, proportion of nulliparae and primigravidae, and smoking. However, women in the sub-sample study were slightly better off than women in the main trial regarding prior low birthweight (LBW) (total population: 5.8% *vs*. sub-sample: 4.0%), gestational age at first visit (total population (mean): 16.2 weeks *vs.* sub-sample (mean): 12.7 weeks) and previous hospital admissions (total population: 1.4% *vs.* sub-sample: 0.8%).

Women in both arms of the study had similar characteristics at trial entry (Table [1](#T1){ref-type="table"}). There were no differences in prior LBW, stillbirths, neonatal losses and conditions of current pregnancy, but women in the standard ANC model (*i.e.*, control clinics) had a slightly higher proportion of previous abortions (34.2% *vs.* 30.4%). Regarding providers in both trial arms, age and years since graduation were similar.

###### 

Baseline characteristics of women enrolled in the satisfaction study, according to ANC model

  **Women\'s Characteristics**                           **New ANC (n = 790)**   **Standard ANC (n = 748)**         
  ------------------------------------------------------ ----------------------- ---------------------------- ----- -------------
  **Married/stable union**                               95                                                   93    
  **Education (less than primary)**                      16                                                   17    
  **Smoking during pregnancy**                           9.5                                                  11    
  **Substance abuse**                                    0.4                                                  0     
  **Ratio of persons/room**                                                      2.4 (1.3)                          2.3 (1.1)
  **Maternal age (years)**                                                       25.5 (5.8)                         25.8 (5.6)
  **Surgery**                                            1.8                                                  0.8   
  **Any previous LBW (\<2500 g)**                        3.9                                                  4     
  **Any previous abortions**                             30                                                   34    
  **Any previous stillbirths or neonatal losses**        3.8                                                  4     
  **PRESENT PREGNANCY:**                                                                                            
  **Iso-Immunization Rh (-)**                            1.3                                                  0.3   
  **Vaginal bleeding first trimester**                   2.4                                                  1.7   
  **LMP unknown**                                        4.3                                                  3.3   
  **Nulliparae**                                         25                                                   27    
  **Primigravidae**                                      29                                                   29    
  **Maternal height (cm)**                                                       157 (6.6)                          156 (6.4)
  **Maternal weight at first visit (kg)**                                        59.2 (12.6)                        58.9 (11.8)
  **Gestational age at first ANC visit (weeks)**                                 13 (5.7)                           12.4 (5)
  **Late booking for ANC (\>28 weeks at first visit)**   2.7                                                  1.7   

For women in the new ANC model, the median was five ANC visits (1^st^ quartile: 4; 3^rd^ quartile: 6) while for those in the standard model it was nine (1^st^ quartile: 6; 3^rd^ quartile: 12). The median waiting time to see a doctor or midwife was shorter (Median: 30\'; 1^st^ quartile: 20, 3^rd^ quartile: 60) for patients in the new model than for those under the standard model (Median: 45\'; 1^st^ quartile: 30, 3^rd^ quartile: 75). There were no differences, however, in time spent with a doctor or nurse for the two arms (median: 15\'; 1^st^ quartile: 10, 3^rd^ quartile: 20).

Women under the new ANC model were slightly less satisfied with the number of visits (77.4% *vs.* 85.2%; 95% CI of the difference: -16.0% to 0.2%) and visit spacing (72.7% *vs.* 81.0%; 95% CI of the difference: -16.8% to 0.3%) than their counterparts in the intervention clinics, although these differences were not statistically significant (Table [2](#T2){ref-type="table"}). Women in both arms of the trial were equally satisfied with waiting time, but those in the new model were more satisfied with the time spent with their provider, although the difference was not significant (85.7% *vs.* 79.1%; 95% CI of the difference:-0. 5% to13.7%) (Table [2](#T2){ref-type="table"}). Adjusting all these outcomes for the baseline abortion rate (which was slightly different among women in the intervention and control groups) did not change the results.

###### 

Women\'s satisfaction with antenatal care, according to ANC model^\*^

  **Satisfaction with:**         **New ANC (%)**   **Standard ANC (%)**   **Adjusted mean difference (%)**   **95%CI**   
  ------------------------------ ----------------- ---------------------- ---------------------------------- ----------- ------
  **Number of visits**           77.4 (789)        85.2 (744)             -7.9                               -16.0       0.2
  **Spacing between visits**     72.7 (782)        81 (744)               -8.3                               -16.8       0.3
  **Waiting time**               78.3 (780)        77.6 (743)             0.7                                -7.4        8.8
  **Time spent with provider**   85.7 (789)        79.1 (747)             6.6                                -0.5        13.7

(Number of women) ^\*^Mean differences and 95% CIs adjusted for strata.

Women in both trial arms were equally satisfied with the information provided by the caregiver about their health, tests during pregnancy and treatment they might need (Table [3](#T3){ref-type="table"}) \[[@B22]\]. However, women in the new ANC model were substantially more satisfied with the information received about normal labor and delivery processes, breastfeeding, family planning, and danger signs (Table [3](#T3){ref-type="table"}).

###### 

Women\'s satisfaction with information on ANC, labor, delivery, and postpartum care, according to ANC model

  **Women satisfied with information received about:**   **New ANC**   **Standard ANC**         
  ------------------------------------------------------ ------------- ------------------ ----- ------
  **Their own health**                                   789           79.7               744   79.5
  **Tests during pregnancy**                             789           86.8               745   83.2
  **Treatment they might need**                          788           62.0               744   68.0
  **Labor and delivery^\*^**                             785           70.0               745   59.5
  **Breastfeeding^\*^**                                  789           76.1               743   67.9
  **Family Planning^\*^**                                788           65.9               744   51.1
  **Rupture of membranes^\*^**                           787           64.3               740   50.5
  **Hemorrhage^\*^**                                     785           73.0               741   57.4
  **Premature contractions^\*^**                         783           73.8               742   59.4
  **Dizziness and fainting**                             782           53.3               742   55.9
  **Fever**                                              779           49.2               741   51.2

^\*^ Significant at 5% (adjusted for simultaneous inferences using Bonferroni method) \[[@B22]\]

During ANC visits, health professionals are usually expected to focus on issues that may worry their patients, a component specially stressed in the new ANC model. Therefore, we asked those women that said they were worried about a specific condition what reassurance they had obtained from their ANC providers (Table [4](#T4){ref-type="table"}) \[[@B22]\]. In general, a similar proportion of women in both trial arms worried about fetal position, size and possible abnormalities, risk of prematurity, and other complications. Providers reassured a higher number of women in the new ANC model clinics, although these differences were not significant (Table [4](#T4){ref-type="table"}).

###### 

Women who were worried about maternal/perinatal conditions and were reassured by provider

  **Perinatal/maternal conditions**   **Women who were worried^\*^**   **Worried women who were reassured^\*^**                                   
  ----------------------------------- -------------------------------- ------------------------------------------ ----- ------ ----- ------ ----- ------
  **Fetal position**                  788                              56.0                                       788   52.2   436   87.2   395   79.8
  **Fetal size**                      788                              52.2                                       740   48.8   406   81.0   355   78.6
  **Prematurity**                     787                              49.7                                       740   48.5   384   81.5   354   73.7
  **Fetal abnormalities**             785                              60.6                                       738   59.1   468   76.7   431   68.5
  **Other complications**             762                              31.5                                       720   29.3   328   85.7   402   86.6
  **Mother\'s own health**            788                              42.6                                       738   55.4   287   88.9   330   87.9
  **Mother\'s own weight**            787                              37.1                                       737   45.2   188   89.9   166   87.4

^\*^ All comparisons non-significant adjusting for simultaneous inferences by Bonferroni method \[[@B22]\]

To assess women\'s overall satisfaction with the information received during ANC, we compared the composite indexes. Overall, women in the experimental clinics were statistically significantly more satisfied with the general information they received (4.4 *vs.*4.0; 95% CI of the difference: 0.1 to 0.7), with information on how to recognize problems (3.0 *vs*. 2.4; 95% CI of the difference: -0.0 to 1.1) and what to do in an emergency (3.0 *vs*. 2.2: 95% CI of the difference 0.1 to 1.3), and on how to recognize problems and what to do (3.4 *vs*. 2.9: 95% CI of the difference 0.1 to1.3.)

Overall satisfaction was measured in the women\'s survey by three affirmative answers to the questions \"If you were pregnant again, would you come back to this clinic?\", \"Would you recommend this clinic to a relative or friend for their antenatal checkups?\" and \"In general, are you satisfied/very satisfied with the ANC you have received in this clinic so far?.\" Women in both arms of the study showed very high levels of satisfaction, and there were no statistically significant differences between groups. The expressed levels of satisfaction were similarly high when women were asked direct and indirect questions. The overall satisfaction index showed that more than 90% of women in both ANC models said that they were \"very satisfied\".

In the case of the providers we did not have a sample; rather it was a census. We distributed the self-administered questionnaire to all health professionals of the clinics where the study was conducted. Providers were slightly more satisfied with the number of visits under the new ANC model (68.5 *vs.* 64.6%); less satisfied with the spacing between visits (60.9 *vs.* 69.5%); and substantially more satisfied with the time spent with each woman (85.9 *vs.* 69.5%). Concerning the information component, providers in general gave themselves higher scores in both ANC models (New ANC: 5.6 STD: 0.9; Standard ANC: 5.2 STD: 1.3) than women did. Finally, most of the health professionals surveyed in the new ANC model qualified the care they provided as \"good\" or \"very good\" (82.7%), while a higher proportion in the standard ANC clinics gave themselves that same score (95.1%).

Discussion
==========

Women in the new ANC model clinics were, in general, as satisfied as their counterparts in the standard model. Furthermore, women in both arms were equally satisfied with waiting time and information provided about their health, tests during pregnancy, and treatment they might need. There were also no significant differences regarding what women worried about and whether the caregiver reassured them. Yet, women in the new ANC model were more satisfied with the time spent with the provider and with the information they received. Providers were more satisfied with the new ANC model with regards to number of visits, time spent with the patient, and information provided, but they were less satisfied with the spacing between visits. More providers rated the overall care provided under the standard model as good or very good than under the new ANC model.

Overall, these results show that both ANC models were equally well accepted by women and providers, suggesting that the adoption of the new antenatal care model would not face major obstacles derived from women or providers\' perception of ANC and their satisfaction with it.

Within this framework, specific issues deserve special attention. In terms of the number of visits and spacing, the qualitative stage findings of our study \[[@B19]\] and those of several previous trials conducted to evaluate ANC models that reduced the number of visits \[[@B15],[@B20],[@B23]-[@B26]\] showed that more women in the intervention groups reported dissatisfaction with a reduced number of visits and longer spacing between them \[[@B20],[@B25]\]. However, our study only demonstrated a trend towards patients\' dissatisfaction with the changes introduced by the new ANC model, as no statistically significant differences between the trial arms were found. In another study conducted in a developing country results were similar to ours: there was no change in patients\' satisfaction with a smaller number of ANC visits and longer spacing between them \[[@B27]\].

Still, our study findings suggest that number of visits and spacing are potential areas of concern for women. Providers could address these concerns by giving women information on the safety of these protocol changes, as was demonstrated by the results of the large WHO trial \[[@B18]\] and the systematic review of all randomized controlled trials \[[@B28]\]. Other needs that work as incentives for women to attend ANC clinics, such as socialization and social support, should be addressed through other activities that do not necessarily involve formal encounters with medical providers.

Regarding time spent with the provider, women in the new model had a higher level of satisfaction with the time spent with the provider than those in the standard model clinics, although the actual duration of the clinical encounter was similar. This positive impression may have resulted from an improvement in the quality of the patient-provider interaction. It is interesting to highlight that although waiting time was effectively reduced, women\'s satisfaction did not reflect the difference (Table [2](#T2){ref-type="table"}).

One of the main goals of the new model was to strengthen the information component \[[@B16]\]. The fact that a larger proportion of women in these clinics perceived that their information needs were satisfactorily met even if there were only five visits to the clinics reveals that the new model was effective in reinforcing this aspect of care. In the Sikorski *et al* trial conducted in London, which achieved only a small reduction in number of visits, provision of information was also stressed; however, they did not find any difference in satisfaction among women in both arms of the trial \[[@B20]\].

The summary questions used to explore overall women\'s satisfaction with ANC showed surprisingly high levels among patients in both models, especially considering that women from the same clinics had expressed concerns about the quality of care during the focus groups and personal interviews conducted during the first stage of this study \[[@B19]\]. A hypothesis to explain this difference is that qualitative techniques capture the feelings of few more outspoken women and may provide a biased perception of the group. This could also be due to a \"courtesy bias\", which usually affects the answers to inquiries about satisfaction with care received, especially when women are asked in clinical settings \[[@B29]\]. In our study, qualitative techniques allowed to discriminate better among women with different levels of satisfaction than close-ended questions, especially the summary ones. This may be due to the wording of questions meant at exploring overall satisfaction; in fact, those that addressed specific issues (such as number of visits, spacing between them, information provided, etc) received answers with more variability.

There is another interesting hypothesis to consider as well. One study in Scotland found that pregnant women are fairly uncritical of health care, accepting whatever care they receive as appropriate. \[[@B30]\] The authors suggest that it would not be surprising to see high levels of overall satisfaction in a controlled study comparing two ANC models, and that it would be important to examine the differences between the two groups studied in their expressed preferences rather than the absolute magnitude of the expressed satisfaction. This was the case with our study, where we were able to differentiate women\'s satisfaction between the two models. However, women in the clinics of both models of ANC seemed to be equally uncritical.

Another difficulty in interpreting our findings derives from the variability in views and expectations originated by various cultural and socio-economic settings. In a study conducted in Chile, for instance, low-income urban women defined high quality as \"being treated as a human being\"; technical quality was not even mentioned \[[@B31]\]. Village women in Thailand identified inequalities of power fundamental to gender, class and ethnic relations as dimensions that crucially affect the client-provider interaction \[[@B32]\]. This was an important challenge in our study. The satisfaction questionnaire we used in each country was standardized with adaptations of terminology only and therefore did not provide any detailed clues about what aspects of ANC women of different cultural backgrounds appreciated more.

Women\'s satisfaction is a sensitive indicator that responds to changes in quality of care, even before changes in health status are detected, \[[@B33]\] but its measurement remains an important challenge. Qualitative methods allow women to reveal their feelings in greater depth than survey research methods \[[@B34]\]. In fact, most studies aimed at exploring women\'s views about quality of reproductive health care resort to interviews and focus groups \[[@B12]\]. However, results obtained with these techniques cannot be extrapolated and have low external validity. Yet, although data collected through questionnaires usually offer more superficial insights and do not reflect cultural nuances, when administered to a representative and large sample they can be safely extrapolated to the population from which the sample was obtained. In an attempt to overcome these limitations, we combined both methodologies \[[@B34]\].

Although our study makes important contributions to the area of users\' perception on changes introduced into ANC models, it does not address methodological issues involved in the measurement of clients\' satisfaction, which other authors have extensively addressed in observational studies \[[@B35],[@B36]\]. In fact, we analyzed the differences between the perspectives of women in the intervention and control clinics, focusing only on those specific aspects that changed as a result of the introduction of the new ANC model (number and spacing of visits, information provided, etc.) Our study did not explore women\'s satisfaction with any other aspects of ANC such as technical quality, physical environment, access and continuity of the provider \[[@B37],[@B38]\] that were not modified with the intervention, or the differences in users\' satisfaction associated with ANC received in different types of facilities (i.e. private or public.) \[[@B39]\]

While users\' perspective of quality of care has been assessed relatively often, the perspective of health professionals has been assessed occasionally at best \[[@B27],[@B40]\]. In our study, while some degree of resistance to the new ANC model was expected, doctors and midwives did not have strong views against it. For instance, providers\' satisfaction with the number of antenatal visits was similar in clinics of both arms of the trial. The reason for this may be that all providers worked at public health institutions, where the number of visits does not have a serious impact on their workload or income. Similar results were obtained in the study conducted in public hospitals in Harare, where the assessment showed that staff wished women made fewer visits to ANC clinics \[[@B27]\]. In the Sikorski trial \[[@B40]\] doctors were in favor of a reduced number of visits, but the average number under routine circumstances was much higher than in the four countries that participated in the WHO trial.

Regarding the information, our study confirmed an imbalance between women\'s expectations and providers\' responses: providers scored themselves higher than their patients did in relation to the information they provide during antenatal check-ups. There appears to be a mismatch between doctors and nurses\' perception of the quality and quantity of the information they provide and the users\' needs. Furthermore, providers should be aware of the importance of meeting women\'s information needs during ANC visits, and thus be prepared to satisfy them.

In matters of overall satisfaction with ANC, although the proportion of providers that said care offered in their clinics was good or very good was high in both arms of the trial, those working in the standard ANC model clinics were more satisfied. This difference could be interpreted as a sign of discontent with the new ANC model.

Conclusions
===========

Increasing attention is given to patients\' views in health care evaluation. Policymakers and program managers should know that women\'s views are determinant in greater acceptance and sustained use of services. Additionally, health professionals\' perspective needs careful evaluation before and during translating new care models into institutional protocols; being a conscious player in the process of change would certainly contribute to improving providers\' commitment to their clinical work.
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